• White Facebook Icon
  • White Blogger Icon
  • White Twitter Icon

We have a special interest in offering a necessary specialist training and invaluable expert mentoring for to develop and improve the valorization plan of the technology developed by the Unit. Also, we have as an objective for our PhD students and postdoctoral researcher to offer the possibility of establishing contact with businesses, entrepreneurs and investor that can give us the opportunity to elaborate an adequate commercialization/business plan that facilitates a possible spin-off /start-up creation. Definitely, we are convincing that our Mnat Unit must also require the transformation of scientific knowledge into a product that creates value in the society, increasing its success probabilities and facilitating access to markets for the benefit of the patients.

PATENTS

 

2017 

WO 2017127892 A1, PCT/AU2017/050065. Cancer treatment. 03/08/2017. Licensed by Propanc Biopharma, Inc

 

P201730415. Dispositivo transluminal […] caracterización mecánica.

 

2016 

WO16/174226A1; PCT/ES2016/059650. Phenol derivated to treat cancer 03/11/2016.

P201630123. Procedimiento para obtención de datos […] ondas de torsión.

P201630715. [(Bencensulfonil)anilino]alquilos unidos a N-9 purinas substituidas a través de un enlace O, Nacetálico, que tienen como objetivo las células madre cancerosas para el tratamiento del cáncer.

 

2015 

PCT/ES2016/070540 + P201500600. Dispositivo emisor de ondas ultrasónicas […].

P201630714, PCT/ES2016/070730. Benzo-heterociclos de seis miembros con átomos de oxígeno y nitrógeno con actividad antitumoral 15/10/2015.

US9166051 B2RAM memory cell comprising a transistor

Inventors/authors/obtainers: Sorin Cristoloveanu; Francisco Gamiz

Entity holder of rights: Universidad de Granada, Centre National De La Recherche Scientifique

US9099544 B2. RAM memory point with a transistor

Inventors/authors/obtainers: Sorin Cristoloveanu; Noel Rodriguez; Francisco Gamiz. Entity holder of rights: Universidad de Granada, Centre National De La Recherche Scientifique

P201630714, PCT/ES2016/070730. Benzo-heterociclos de seis miembros con átomos de oxígeno y nitrógeno con actividad antitumoral 15/10/2015.

 

2014 

P20140066; PCT/ES2015/070606, WO2016/020572 A1, US 15/501,718. Culture medium and method for enriching and maintaining cancer stem cells (CSCs) using said medium27/08/2014.

P201400282. Dispositivo de guía para mosaicoplastia España. 04/04/2014. Licensed by VIDIA HEALTH S.A.

P201430048. Sulfonamidas derivadas de aminas secundarias con grupos 1,3-dioxolanilalquílicos, y su utilización como agentes anticancerígenos España. 20/01/2014.

JP5612076 (B2). RAM MEMORY ELEMENT WITH ONE TRANSISTOR

Inventors/authors/obtainers: Sorin Cristoloveanu; Noel Rodriguez; Francisco Gamiz

Entity holder of rights: Universidad de Granada, Centre National de la Recherche Scientifique

 

2013 

EP13382436.7; US-2016-0273047 A1. Epithelial-mesenchymal transition in circulating tumor cells (CTCs) negatives for cytokeratin (CK) expression in patients with nonmetastatic breast cancer 30/12/2013. Licensed by VIDIA HEALTH S.A.

P201301204. Dispositivo para fijación de injerto en mosaicoplastia de tracción España. 26/12/2013. Licensed by VIDIA HEALTH S.A.

P201301203. Dispositivo para la inserción y extracción del injerto en mosaicoplastia de tracción España. 26/12/2013. Licensed by VIDIA HEALTH S.A.

P201300753. Antitumor gene therapy. 26/07/2013. Licensed by VIDIA HEALTH S.A.

RESEARCH & DEVELOPMENT

CONTRACTS

Canvax Biotech SL: Síntesis de nuevas moléculas de interés farmacológico de Canvax, 98000 €

BRECA Health Care SL: Pruebas de validación y optimización con células, 16940€

PKR EXOGENETICS SL: Detección de biomarcadores en pacientes con cáncer de colon tratados con quimioterapia y terapias biológicas para el desarrollo de un test útil de diagnóstico, 478622€

Bioibérica SL. Evaluación y Desarrollo de biotintas para bioimpresión 3D con aplicación en terapia celular. 14.000 €

Destina Genomics. Ltd. Desarrollo de sondas DGL y nucleobases Smart para identificación de miRNAs específicos en sueros de pacientes mediante química dinámica. 10.000 €

Regemat 3D (http://www.regemat3d.com/)

PKR-Exogenetics SL (http://spinoff.ugr.es/showcase/company/pkr-exogenetics-sl/

Oritia & Boreas Wind Engineering (www.oritiayboreas.com

ASSOCIATED START-UPS

& SPINOFFS

1/1

The multidisciplinary research of our unit of excellence is reflected by collaborations between different groups belonging to the field of applied physics, applied mathematics, electronic engineering, bioinformatics, medical bioengineering, organic and pharmaceutical chemistry, pharmacology, biotechnology or experimental oncology among others. This multidisciplinarity has allowed an innovative research and the transference through the protection of knowledge in order to facilitate the use, application and exploitation outside the academic field, either with other R & D institutions, the productive sector or society in general. We have generated technological innovations, patents or utility models and even the creation of new start-up and new Spinoffs.

Moreover, several members of the Unit are enrolled in the “Technology Promoters” pilot program of the TTO (Technology Transfer Office) of the University of Granada. At the moment, they have attending skill training activities and initiatives in innovation management, technology transfer, 

marketing and plan business that include topics about valorization and protection of research results, for instance, patents and utility models or

the use of databases as sources of patent technology information.

 
 

Photo by J. M. Melchor